Structures of soluble amyloid oligomers from computer simulations

Proteins: Structure, Function and Genetics

Volumn 65, Issue 1, 2006, Pages 180-191

  Melquiond, Adrien ^a   Mousseau, Normand ^b   Derreumaux, Philippe ^a  

^a France   (France)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Activation relaxation technique; Aggregation; Amyloid fibril formation; Coarse grained force field; Molecular dynamics; Protein simulations; Soluble oligomers

Indexed keywords

AMYLOID;

ACTIVATION RELAXATION TECHNIQUE; ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; BETA SHEET; COMPUTER SIMULATION; CREUTZFELDT JAKOB DISEASE; CYTOTOXICITY; DEGENERATIVE DISEASE; EFFICIENT PEPTIDE STRUCTURE PREDICTION; MOLECULAR DYNAMICS; OLIGOMERIZATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

AMYLOID; COMPUTER SIMULATION; HUMANS; PHENYLALANINE; PROTEIN FOLDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY;

EID: 33748278029     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21100     Document Type: Article

References (50)

1. Koo EH, Lansbury PT, Jr, Kelly JW. Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc Natl Acad Sci USA 1999;96:9989,9990.
2. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002;298:789-791.
3. Prusiner SB. Prion diseases and the BSE crisis. Science 1997;278: 245-251.
4. Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, Eisenberg D. Structure of the cross-β spine of amyloid-like fibrils. Nature 2005;435:773-778.
5. Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP, Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 2005;307:262-265.
6. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002;416:507-511.
7. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003;300:486-489.
8. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat Neurosci 2005;8:79-84.
9. Bitan G, Vollers SS, Teplow DB. J Biol Chem 2003;278:34882-34889.
10. Cellmer T, Bratko D, Prausnitz JM, Blanch H. Protein-folding landscapes in multichain systems. Proc Natl Acad Sci USA 2005; 102:11692-11697.
11. Armen RS, DeMarco ML, Alonso DO, Daggett V. Pauling and Corey's α-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease. Proc Natl Acad Sci USA 2004;101:11622-11627.
12. 10-35): sequence effects. Proc Natl Acad Sci USA 2002;99:14126-14131.
13. Haspel N, Zanuy D, Ma B, Wolfson H, Nussinov R. A comparative study of amyloid fibril formation by residues 15-19 of the human calcitonin hormone: a single β-sheet model with a small hydrophobic core. J Mol Biol 2005;345:1213-1227.
14. Stork M, Giese A, Kretzschmar HA, Tavan P. MD simulations indicate a possible role of parallel β-helices in seeded aggregation of poly-Gln. Biophys J 2005;88:2442-2451.
15. 10-35-protein: assessing the propensity for peptide dimerization. J Mol Biol 2005;345:1141-1156.
16. Lopez de la Paz M, de Mori GM, Serrano L, Colombo G. Sequence dependence of amyloid fibril formation: insights from molecular dynamics simulations. J Mol Biol 2005;349: 583-596.
17. Colombo G, Daidone I, Gazit E, Amadei A, Di Nola A. Molecular dynamics simulation of the aggregation of the core-recognition motif of the islet amyloid polypeptide in explicit water. Proteins 2005;59:519-527.
18. Soto P, Cladera J, Mark AE, Daura X. Stability of SIV gp32 fusion-peptide single-layer protofibrils as monitored by molecular-dynamics simulations. Angew Chem Int Ed Engl 2005;44:1065-1067.
19. Tsai HH, Reches M, Tsai CJ, Gunasekaran K, Gazit E, Nussinov R. Energy landscape of amyloidogenic peptide oligomerization by parallel-tempering molecular dynamics simulation: significant role of Asn ladder. Proc Natl Acad Sci USA 2005;102:8174-8179.
20. 16-22 amyloid peptides into antiparallel β sheets. Structure 2003;11: 295-307.
21. Paci E, Gsponer J, Salvatella X, Vendruscolo M. Molecular dynamics studies of the process of amyloid aggregation of peptide fragments of transthyretin. J Mol Biol 2004;340:555-569.
22. Wu C, Lei H, Duan Y. The role of Phe in the formation of well-ordered oligomers of amyloidogenic hexapeptide (NFGAIL) observed in molecular dynamics simulations with explicit solvent. Biophys J 2005;88:2897-2906.
23. Gsponer J, Haberthur U, Caflisch A. The role of side-chain interactions in the early steps of aggregation: molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35. Proc Natl Acad Sci USA 2003;100:5154-5159.
24. Hwang W, Zhang S, Kamm RD, Karplus M. Kinetic control of dimer structure formation in amyloid fibrillogenesis. Proc Natl Acad Sci USA 2004;101:12916-12921.
25. Nguyen ND, Hall CK. Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. Proc Natl Acad Sci USA 2004;101:16180-16185.
26. Urbanc B, Cruz L, Yun S, Buldyrev SV, Bitan G, Teplow DB, Stanley HE. In silico study of amyloid β-protein folding and oligomerization. Proc Natl Acad Sci USA 2004;101:17345-17350.
27. Tjernberg L, Hosia W, Bark N, Thyberg J, Johansson J. Charge attraction and β propensity are necessary for amyloid fibril formation from tetrapeptides. J Biol Chem 2002;277:43243-43246.
28. Melquiond A, Boucher G, Mousseau N, Derreumaux P. Following the aggregation of amyloid-forming peptides by computer simulations. J Chem Phys 2005;122:174904.
29. Wei GH, Mousseau N, Derreumaux P. Sampling the self-assembly pathways of KFFE hexamers. Biophys J 2004;87:3648-3656.
30. Wei GH, Mousseau N, Derreumaux P. Assembly dynamics of KFFE octamers. J Phys Condens Matter 2004;16:5047-5054.
31. 16-22 peptide assembly. Structure 2004;12:1245-1255.
32. 16-22 peptide into β-sheets. J Am Chem Soc 2004;126:11509-11516.
33. Barkema GT, Mousseau N. Event-based relaxation of continuous disordered systems. Phys Rev Lett 1996;77:4358-4361.
34. Malek R, Mousseau N. Dynamics of Lennard-Jones clusters: a characterization of the activation-relaxation technique. Phys Rev E 2000;62:7723-7728.
35. Wei GH, Mousseau N, Derreumaux P. Complex folding pathways in a simple β-hairpin. Proteins 2004;56:464-474.
36. Mousseau N, Derreumaux P. Exploring the early steps of amyloid peptide aggregation by computers. Acc Chem Res 2005;38: 885-891.
37. 16-22 peptides using hydrogen bonds and hydrophobicity forces. Biophys J 2004;87:3657-3664.
38. Mousseau N, Derreumaux P, Gilbert G. Navigation and analysis of the energy landscape of small proteins using the activation-relaxation technique. Phys Biol 2005;2:S101-S107.
39. Derreumaux P. From polypeptide sequences to structures using Monte Carlo simulations and an optimized potential. J Chem Phys 1999;111:2301-2310.
40. Derreumaux P. Generating ensemble averages for small proteins from extended conformations by Monte Carlo simulations. Phys Rev Lett 2000;85:206-209.
41. Derreumaux P. Role of supersecondary structural elements in protein G folding. J Chem Phys 2002;117:3499-3503.
42. Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983;22:2577-2637.
43. Berendsen HJC, van der Spoel D, Van Drunen R. GROMACS: a message-passing parallel molecular dynamics implementation. Comput Phys Commun 1995;91:43-56.
44. Humphrey W, Dalke A, Schulten K. "VMD-visual molecular dynamics." J Mol Graph 1996;14:33-38.
45. 16-22 peptide. J Am Chem Soc 2005;127:13488, 13489.
46. Wu C, Lei H, Duan Y. Elongation of ordered peptide aggregate of an amyloidogenic hexapeptide NFGAIL observed in molecular dynamics simulations with explicit solvent. J Am Chem Soc 2005;127:13530-13537.
47. Moroni D, ten Wolde PR, Bolhuis PG. Interplay between structure and size in a critical crystal nucleus. Phys Rev Lett 2005;94: 235703.
48. Yong W, Lomakin A, Kirkitadze MD, Teplow DB, Chen SH, Benedek GB. Structure determination of micelle-like intermediates in amyloid β-protein fibril assembly by using small angle neutron scattering. Proc Natl Acad Sci USA 2002;99:150-154.
49. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, Lansbury PT, Jr. α-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 2002;322:1089-1102.
50. Serio TR, Cashikar AG, Kowal AS, Sawicki GJ, Moslehi JJ, Serpell L, Arnsdorf MF, Lindquist SL. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 2000;289:1317-1321.